Optimal management of venous thromboembolism (VTE) hinges upon understanding the medical, economic, and psychosocial consequences of pulmonary embolism (PE) and deep vein thrombosis (DVT). In an international registry of 23,858 patients with acute PE over 13 years, the mean length…
Venous thromboembolism (VTE), most often presenting as deep vein thrombosis (DVT) or pulmonary embolism (PE), is a frequently encountered cardiovascular disorder. After myocardial infarction and stroke, VTE is the third most common cardiovascular disease with an estimated 10 million cases…
Thromboangiitis obliterans (TAO) describes a segmental, nonatherosclerotic inflammatory disorder that primarily involves the small and medium arteries, veins, and nerves of the extremities. Although TAO was initially thought to be a disease confined exclusively to men, epidemiologic studies demonstrate a…
Additional content is available online at Elsevier eBooks for Practicing Clinicians Venous thromboembolic disease (VTE), comprising both pulmonary embolism (PE) and deep vein thrombosis (DVT), contributes to substantial cardiovascular morbidity and mortality. PE causes more than 100,000 deaths annually in…